Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, reflecting a new metadata version for the page. No content or functionality changes are introduced.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than any change to the study record content.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision: v3.5.2 has been added and Revision: v3.5.0 has been removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded Revision: v3.4.2 and removed the previous funding-status notice (v3.4.1) as part of the site update. These updates do not alter the trial information or how users access it.SummaryDifference0.4%

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.